Sam is a professional trader and the lead stock market news writer at AskTraders. After starting his career in the forex market, Sam now focuses on gold and stocks with a preference for fundamental and macroeconomic analysis.
Shares of medical and rehabilitation equipment manufacturer, Dynatronics (NASDAQ: DYNT) are surging premarket after the company yesterday announced that its wholly-owned subsidiary, Bird & Cronin, renewed its purchasing agreement with Intalere.
Bird & Cronin has been an Intalere preferred provider for over twenty years.
As part of the deal, Intalere members will receive negotiated pricing on Bird & Cronin’s full line of orthopaedic bracing solutions for spine, upper and lower extremities. These include products such as the Sprint air walker boot and U2TMwrist brace.
Intalere has more than 100,000 members from healthcare organisations across the United States, with members making nearly $9 billion in purchases annually.
“The twenty-plus year relationship with Intalere has allowed Bird & Cronin to provide healthcare providers with Bird & Cronin's high-quality products at the right cost,” said John Krier, CEO of Dynatronics.
Dynatronic’s shares are trading 142% higher premarket, at $3.10, following Wednesday’s 5% increase to $1.28 per share.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage . 75 % of retail investor accounts lose money when trading CFDs with this provider . You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money .